Login to Your Account



Other News To Note


Monday, June 24, 2013
Bellus Health Inc., of Laval, Quebec, and Thallion Pharmaceuticals Inc., of Dorval, Quebec, said Bellus agreed to acquire Thallion for about $6.3 million in cash, or about 17 cents per share (on a fully diluted basis), subject to certain adjustments, and the issuance of contingent value rights (CVRs).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription